Exposure and Response Prevention Therapy: Clinical Trials

5 trials of Exposure and Response Prevention Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Unknown 1, Withdrawn 1
Phase 11Completed 1
Phase 21Completed 1

Follow Exposure and Response Prevention Therapy: new trials by email Literature Review of Exposure and Response Prevention Therapy trials Research Report on Exposure and Response Prevention Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder
Exposure and Response Prevention Therapy, Clinical Assessments, Research MRI Sessions - Obsessive-Compulsive Disorder
Not applicableWithdrawnWeill Medical College of Cornell University2026-11-012026-08-05
Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment
Exposure and response prevention therapy - Obsessive-Compulsive Disorder
CompletedNOCD21732020-07-232024-06-26
Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
Exposure and response prevention therapy - Obsessive-Compulsive Disorder
CompletedNOCD20692020-01-012021-01-08
Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder
Exposure and Response Prevention Therapy - Obsessive-Compulsive Disorder
Not applicableUnknownRuijin Hospital482016-11-012016-11-29
Cannabinoid Medication for Adults With OCD
Nabilone, Exposure and Response Prevention Therapy - Obsessive-Compulsive Disorder
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute162016-09-012020-08-06

Conditions studied

Obsessive-Compulsive Disorder (5)

Sponsors

NOCD (2)  ·  New York State Psychiatric Institute (1)  ·  Ruijin Hospital (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (4)  ·  China (1)

Top investigators

Bomin Sun, MD, PhD (1)  ·  Conor Liston, MD, PhD (1)  ·  Helen B Simpson, M.D., Ph.D. (1)